Cryosite Limited (AU:CTE) has released an update.
Cryosite Limited has reported robust performance and strong cash flow, with plans to expand storage capacity and delve into biological storage and cell & gene therapy services. The company has also appointed Scott Thomas, who brings extensive financial experience, as a new Director. Shareholders are informed that Cryosite aims to pay further dividends in the current year following a successful audit of FY24 financials.
For further insights into AU:CTE stock, check out TipRanks’ Stock Analysis page.
